Bioton SA
WSE:BIO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bioton SA
WSE:BIO
|
PL |
|
P
|
Pensana PLC
F:48W
|
UK |
|
Shanghai Rural Commercial Bank Co Ltd
SSE:601825
|
CN |
|
Ambuja Cements Ltd
NSE:AMBUJACEM
|
IN |
|
Rajesh Exports Ltd
NSE:RAJESHEXPO
|
IN |
|
Xpeng Inc
NYSE:XPEV
|
CN |
|
Dorel Industries Inc
F:DO4B
|
CA |
|
Chill Brands Group PLC
LSE:CHLL
|
UK |
|
Uttam Sugar Mills Ltd
NSE:UTTAMSUGAR
|
IN |
Bioton SA
BIOTON SA engages in the manufacture and production of medicine and pharmaceutical substances. The company is headquartered in Warsaw, Woj. Mazowieckie and currently employs 371 full-time employees. The company went IPO on 2005-03-16. The firm is engaged in research, development and wholesale trade of pharmaceutical and biotechnological products. The firm's portfolio consists of oral hypoglycemic drugs (metformin and glimepride) as well as recombinant human insulin in pharmaceutical substance form and for injections. Additionally, the Company provides advertising services. As of December 31, 2011, the Company formed a capital group and operated through its subsidiaries, including BIOTON TRADE Sp. z o.o., Mindar Holdings Ltd, Germonta Holdings Ltd, Tricel SA, SciGen Ltd and BioPartners Holdings AG, among others. On June 12, 2014, it sold a 50% stake in Copernicus Sp. z o.o.
BIOTON SA engages in the manufacture and production of medicine and pharmaceutical substances. The company is headquartered in Warsaw, Woj. Mazowieckie and currently employs 371 full-time employees. The company went IPO on 2005-03-16. The firm is engaged in research, development and wholesale trade of pharmaceutical and biotechnological products. The firm's portfolio consists of oral hypoglycemic drugs (metformin and glimepride) as well as recombinant human insulin in pharmaceutical substance form and for injections. Additionally, the Company provides advertising services. As of December 31, 2011, the Company formed a capital group and operated through its subsidiaries, including BIOTON TRADE Sp. z o.o., Mindar Holdings Ltd, Germonta Holdings Ltd, Tricel SA, SciGen Ltd and BioPartners Holdings AG, among others. On June 12, 2014, it sold a 50% stake in Copernicus Sp. z o.o.
